Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats

Inflammation

Volumn 37, Issue 4, 2014, Pages 1167-1178

  Kilic, Talat ^a   Parlakpinar, Hakan ^a   Polat, Alaadin ^a   Taslidere, Elif ^a   Vardi, Nigar ^a   Sarihan, Ediz ^a   Ermis, Hilal ^a   Tanbag, Kevser ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

bleomycin; idiopathic pulmonary fibrosis; inflammation; molsidomine; pulmonary fibrosis

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MOLSIDOMINE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; BLEOMYCIN; NITRIC OXIDE DONOR; PEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENERAL PATHOLOGICAL PARAMETERS; HISTOPATHOLOGY; LUNG PARENCHYMA; MULTIPLE CYCLE TREATMENT; NONHUMAN; OXIDATIVE STRESS; PROPHYLAXIS; RAT; THERAPY EFFECT; TISSUE LEVEL; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; TREATMENT RESPONSE; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; INFLAMMATION; LUNG FIBROSIS; LUNG LAVAGE; METABOLISM; WISTAR RAT;

ANIMALIA; RATTUS; TOSCANA VIRUS;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE; CATALASE; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INFLAMMATION; MALONDIALDEHYDE; MOLSIDOMINE; NITRIC OXIDE DONORS; OXIDATIVE STRESS; PEROXIDASE; PULMONARY FIBROSIS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84904730336     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9841-1     Document Type: Article

References (51)

1. Raghu, G., H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, J.A. Lasky, et al. 2011. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine 183: 788-824.
2. Gross, T.J., and G.W. Hunninghake. 2001. Idiopathic pulmonary fibrosis. New England Journal of Medicine 345: 517-525. (Pubitemid 32758505)
3. Dedon, P.C., and I.H. Goldberg. 1992. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chemical Research in Toxicology 5: 311-332.
4. Cottin, V. 2013. The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis. Respiratory Research 14(1): 5. doi:10.1186/1465-9921-14-S1- S5.
5. Mata, M., A. Ruíz, M. Cerdá, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo. 2003. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. European Respiratory Journal 22(6): 900-905. (Pubitemid 37540639)
6. Sogut, S., H. Ozyurt, F. Armutcu, et al. 2004. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. European Journal of Pharmacology 494: 213-220. (Pubitemid 38798107)
7. Yildirim, Z., Y. Turkoz, M. Kotuk, et al. 2004. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 11: 156-165. (Pubitemid 39371093)
8. Yildirim, Z., M. Kotuk, H. Erdogan, M. Iraz, M. Yagmurca, I. Kuku, and E. Fadillioglu. 2006. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. Journal of Pineal Research 40: 27-33.
9. Iraz, M., H. Erdogan, M. Kotuk, M. Yagmurca, T. Kilic, H. Ermis, E. Fadillioglu, and Z. Yildirim. 2006. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacological Research 53: 310-316. (Pubitemid 43247545)
10. Akgedik, R., S. Akgedik, H. Karamanli, S. Uysal, B. Bozkurt, D. Ozol, F. Armutcu, and Z. Yildirim. 2012. Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation 35(5): 1732-1741.
11. Ermis, H., H. Parlakpinar, G.Gulbas, N. Vardi, A. Polat, A. Cetin, T. Kilic, and Z.A. Aytemur. 2013. Protective effect of dexpanthenol on bleomycin-induced pulmonary fibrosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. doi:10.1007/s00210-013-0908.
12. Gupta, A., S. Sharma, and K. Chopra. 2008. Reversal of iron-induced nephrotoxicity in rats bymolsidomine, a nitric oxide donor. Food and Chemical Toxicology 46(2): 537-543. (Pubitemid 350297535)
13. Kukovetz, W.R., and S. Holzmann. 1986. Cyclic GMP as the mediator of molsidomine-induced vasodilatation. European Journal of Pharmacology 122: 103-109. (Pubitemid 16023421)
14. Valdivielso, J.M., and R.C. Blantz. 2002. Acute renal failure: Is nitric oxide the bad guy? Redox Signaling 4: 925-934. (Pubitemid 36042468)
15. Walder, C.E., C. Thiemermann, and J.R. Vane. 1991. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. British Journal of Pharmacology 102: 967-973.
16. Garcia-Criado, F.J., N. Eleno, F. Santos-Benito, et al. 1998. Protective effect of exogenous nitric oxide on the renal function and inflammatory reaction in a model of ischemia-reperfusion. Transplantation 66: 982-990. (Pubitemid 28513374)
17. Chander, V., and K. Chopra. 2005. Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats. Journal of Surgical Research 128(1): 132-139. (Pubitemid 41188221)
18. Marios, A.M., and V. Aidinis. 2011. Modeling pulmonary fibrosis with bleomycin. Current Opinion in Pulmonary Medicine 17: 355-361.
19. Colak, C., and H. Parlakpinar. 2012. Hayvan Deneyleri: In vivo Denemelerin Bildirimi: ARRIVE Kilavuzu-Derleme. Journal of Turgut Ozal Medical Center 19(2): 128-131.
20. Uchiyama, M., and M. Mihara. 1978. Determination of malonaldehyde precursor in tissues by tiobarbituric acid test. Analytical Biochemistry 34: 271-278. (Pubitemid 9050395)
21. Sun, Y., L. Oberley, and Y. Li. 1988. A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34: 497-500.
22. Aebi, H. 1974. Catalase. In Methods of enzymatic analysis, ed. H.U. Bergmeyer, 673-677. New York: Academic.
23. Paglia, D.E., and W.N. Valentine. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70: 158-170.
24. Ellman, G.L. 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82: 70-77.
25. Wei, H., and K. Frenkel. 1993. Relationship of oxidative events and DNA oxidation in Sencar mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 14: 1195-1201. (Pubitemid 23193551)
26. Erel, O. 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clinical Biochemistry 37: 277-285. (Pubitemid 38314881)
27. Erel, O. 2005. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 38: 1103-1111.
28. Coward, W.R., G. Saini, and G. Jenkins. 2010. The pathogenesis of idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease 4: 367-388.
29. Harari, S., and A. Caminati. 2010. IPF: New insight on pathogenesis and treatment. Allergy 65: 537-553.
30. Chaudhary, N.I., A. Schnapp, and J.E. Park. 2006. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. American Journal of Respiratory and Critical Care Medicine 173: 769-776. 352006.
31. Mungunsukh, O., A.J. Griffin, Y.H. Lee, and R.M. Day. 2010. Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 298: 696-703.
32. Mouratis, M.A., and V. Aidinis. 2011. Modeling pulmonary fibrosis with bleomycin. Current Opinion in Pulmonary Medicine 17: 355-361.
33. Sleijfer, S. 2001. Bleomycin-induced pneumonitis. Chest 120: 617-624. (Pubitemid 32881285)
34. Valko, M., D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser. 2007. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology 39: 44-84. (Pubitemid 44566469)
35. Cortijo, J., M. Cerda-Nicolas, A. Serrano, G. Bioque, J.M. Estrela, F. Santangelo, et al. 2001. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. European Respiratory Journal 17: 1228-1235. (Pubitemid 32717483)
36. Ross, D. 1988. Glutathione, free radicals and chemotherapeutic agents. Pharmacology and Therapeutics 37: 231-249.
37. Venkatesan, N., V. Punithavathi, and G. Chandrakasan. 1997. Curcumin protects bleomycin-induced lung injury in rats. Life Sciences 61: L51-L58.
38. Kang, J.L., W. Park, I.S. Pack, H.S. Lee, M.J. Kim, C.M. Lim, et al. 2002. Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation. Journal of Applied Physiology 92: 795-801. (Pubitemid 34671050)
39. Hong-ping, X.I.A., H. Guo-ying, Z.H.U. Jian-xing, and S.U.N. Bo. 2008. Effect of inhalation of nebulized NO donor substance on acute hypoxic lung injury in newborn piglets. Chinese Medical Journal 121(17): 1622-1626.
40. Kinsella, J.P., T.A. Parker, and H. Galan. 1997. Effects of inhaled nitric oxide on pulmonary edema and lung neutophil accumulation in severe experimental hyaline membrane disease. Pediatric Research 41(Pt 1): 457-463. (Pubitemid 27147859)
41. Fukatsu, K., H. Saito, I.Han, et al. 1998. Nitric oxide donor decreases neutrophil adhesion in both lung and peritoneum during peritonitis. Journal of Surgical Research 74: 119-124. (Pubitemid 28270359)
42. Cao, L., L.L. Qian, Y.R. Zhu, C.B. Guo, X.H. Gong, and B. Sun. 2003. Regulation of activity of nuclear factor-kappa B and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacologica Sinica 24: 1316-1323. (Pubitemid 37509446)
43. Bentli, R., H. Parlakpinar, A. Polat, et al. 2013. Molsidomine prevents cisplatin-induced hepatotoxicity. Archives of Medical Research 44: 521-528.
44. Disli, O.M., E. Sarihan, M.C. Colak, et al. 2013. Effects of molsidomine against doxorubicin-induced cardiotoxicity in rats. European Surgical Research 51: 79-90.
45. Grisham, M.B. 1995. Interaction between nitric oxide and superoxide: role in modulating leukocyte adhesion in the postischemic microvasculature. Transplantation Proceedings 27: 2842.
46. Clancy, R.M., J. Leszczynska-Piziak, and S.B. Abramson. 1992. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. Journal of Clinical Investigation 90: 1116.
47. Aoki, F., M. Kurabayashi, Y. Hasegawa, and I. Kojima. 2005. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. American Journal of Respiratory and Critical Care Medicine 172: 713-720. (Pubitemid 41324226)
48. Kakugawa, T., H.Mukae, T. Hayashi, H. Ishii, K. Abe, T. Fujii, et al. 2004. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis. European Respiratory Journal 24: 57-65. (Pubitemid 39029069)
49. Peters, H., et al. 2003. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis. Kidney International 64: 509-518. (Pubitemid 36871922)
50. Giri, S.N., I. Biring, T. Nguyen, et al. 2002. Abrogation of bleomycin induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice. Nitric Oxide 7: 109-118. (Pubitemid 35177002)
51. Chen, X.L., W.B. Li, A.M. Zhou, et al. 2003. Role of endogenous peroxynitrite in pulmonary injury and fibrosis induced by bleomycin A5 in rats. Acta Pharmacologica Sinica 24: 697-702.